How Does AKG Support Learning, Memory, and Antidepressant Effects?

Background

The beneficial effects of exercise on cognitive function and mental well-being have been well documented, yet the molecular mediators underlying these effects remain incompletely understood.

Alpha-Ketoglutarate (AKG) is a key metabolic intermediate of the tricarboxylic acid (TCA) cycle, and its serum levels have been shown to increase significantly following exercise. The study discussed in this article therefore investigated whether AKG may serve as a potential exercise-related metabolic mediator, contributing to improvements in learning and memory as well as depression-like behaviors.

These findings provide new insights into the potential connection between exercise, cellular metabolism, and brain health, highlighting AKG as a promising metabolic factor for further research in cognitive and mental health applications.
 

Research Design

A research team led by Sleiman at the American University of Beirut investigated the potential role of alpha-ketoglutarate (AKG) in exercise-related cognitive and behavioral benefits using male C57BL/6J mice as an experimental model.

The study employed three complementary approaches: exercise intervention, direct AKG administration, and stress-induced behavioral intervention. Spatial learning and associative memory were evaluated using the Morris water maze and fear-conditioning tests, respectively.

To investigate potential antidepressant-like effects, researchers established a chronic social defeat stress (CSDS) model to induce depression-like behaviors. In addition, Western blot analysis was performed to examine the protein expression levels of brain-derived neurotrophic factor (BDNF) and its upstream regulator PGC-1α in the hippocampus and nucleus accumbens (NAc).

This multi-dimensional experimental design enabled researchers to explore the potential links between AKG, exercise, cognitive function, stress-related behaviors, and neurotrophic signaling.

Research Results

Both voluntary wheel running and resistance exercise significantly increased serum AKG levels in mice. Following five consecutive days of intraperitoneal AKG administration (300 mg/kg), mice showed a significantly faster spatial learning curve in the Morris water maze, along with enhanced contextual and auditory fear-associated memory in the fear-conditioning test.

To determine whether AKG mediates the memory-enhancing effects of exercise, researchers administered the glutaminase inhibitor JHU-083 to block downstream AKG production in exercising mice. This intervention significantly reduced both spatial learning performance and memory recall, providing evidence that AKG may play an important role in mediating the cognitive benefits associated with exercise.

In the chronic social defeat stress (CSDS) model, AKG pretreatment for five days before stress exposure effectively promoted stress resilience. Compared with the saline-treated group, AKG-treated mice showed a significantly higher social interaction ratio, indicating effective prevention of stress-induced social avoidance.

Notably, AKG did not significantly improve stress-related anxiety-like behaviors, suggesting that its behavioral effects may be selective, with a more pronounced impact on learning, memory, and stress resilience rather than generalized anxiety-related behaviors.

At the mechanistic level, AKG pretreatment produced distinct, region-specific effects on BDNF signaling in different brain regions.

In the hippocampus, chronic social defeat stress (CSDS) significantly reduced BDNF levels. AKG pretreatment restored hippocampal BDNF expression to near-normal levels, accompanied by an increase in the upstream regulatory factor PGC-1α.

In contrast, in the nucleus accumbens (NAc), CSDS induced an abnormal increase in BDNF expression. AKG pretreatment effectively prevented this elevation, and this effect appeared to be independent of PGC-1α regulation.

These findings suggest that AKG may regulate BDNF signaling in a brain-region-specific manner, rather than simply increasing BDNF throughout the brain.

Therapeutic Findings

In a treatment paradigm, susceptible mice that had already developed social avoidance behaviors received AKG for 14 consecutive days. AKG treatment significantly increased the social interaction ratio and effectively reversed stress-induced social avoidance.

Together, these findings suggest that AKG may have both preventive and therapeutic potential for stress-related behavioral changes, while highlighting the importance of its region-specific neurobiological mechanisms.

Research Summary

This study identified Alpha-Ketoglutarate (AKG) as a circulating factor released in response to exercise, demonstrating its potential to promote spatial learning and associative memory while also exhibiting both preventive and therapeutic effects against social avoidance induced by chronic social defeat stress.

Mechanistically, AKG appears to regulate BDNF signaling in a brain-region-specific manner. In the hippocampus, AKG restores BDNF levels through the PGC-1α–BDNF pathway, while in the nucleus accumbens (NAc), it suppresses abnormal BDNF elevation through a mechanism that is independent of PGC-1α. These findings highlight a potential metabolic link between exercise, AKG signaling, and brain function.

Safety Evaluation

Nanning Hanhe Bio supplied 99.9% pure Calcium Alpha-Ketoglutarate (Ca-AKG), batch No. 20260116003. Toxicity testing was conducted from March 20 to April 10, 2026, by Guangzhou Yike Biotechnology Co., Ltd., a testing organization holding multiple accreditations, including MA, CNAS, and CMA.

The results indicated that Ca-AKG showed no apparent toxicity at the tested doses, providing preliminary safety support for its potential development as a functional ingredient.

Note: The animal study described above investigated AKG rather than necessarily the calcium salt form, Ca-AKG. Therefore, the research findings should not be interpreted as direct clinical evidence for Ca-AKG in humans.
 

Application Prospects

This study demonstrates the potential of Alpha-Ketoglutarate (AKG) as an exercise-derived circulating factor involved in neuroregulation, providing a scientific basis for the development of AKG-based functional products and opening new opportunities for differentiated applications in the broader health and nutrition market.

Building on its potential roles in supporting learning and memory and regulating mood, future product development could explore applications in sports nutrition, such as nutritional products designed to support physical recovery and cognitive fatigue management, as well as in the fields of cognitive wellness and mood support, including functional foods targeting stress management and emotional well-being.

Nanning Hanhe Bio has independently developed 99.9% high-purity Calcium Alpha-Ketoglutarate (Ca-AKG). The ingredient has undergone acute toxicity and cytotoxicity evaluations at an accredited laboratory, with no apparent organ damage or cytotoxic effects observed under the tested conditions, providing preliminary safety support for further product development.

Hanhe Bio is also continuing to advance human clinical research to generate more comprehensive evidence regarding the safety and functional benefits of AKG-based products.

（This article is intended for academic exchange and informational purposes only. It does not constitute medical or health advice. Please consult a qualified healthcare professional for any health-related concerns.)

Reference

Eid F, El Ahmad P, Khoury R, et al. α-Ketoglutarate Is a Circulatory Exercise Factor That Promotes Learning and Memory Recall and Has Antidepressant Properties. Biol Psychiatry Glob Open Sci. 2025;5:100477.